Decisions 28th June 2017

At the meeting that took place on 28th June, the following decisions were agreed.

New drug requests


Budesonide foam enema (TLS blue)

  • For treatment of ulcerative proctatitis, left sided ulcerative colitis and left sided colonic Crohns disease.

Fiasp Insulin (TLS red)

  • For management of diabetes in a select cohort of patients where post-prandial hyperglycaemia (PPH) is a particular problem, that is pregnant patients or those with T1DM on insulin pumps who are experiencing PPH on novorapid.

Ibandronic Acid (TLS red)

  • For hypercalcaemia of malignancy in patients with renal impairment (<30ml/min)

Cilodex ear drops (TLS green)

  • For ear infections as per microbial sensitivities and post-surgery prophylaxis.

Shared Care Protocols/TLS change in status


Other items

Infanrix Hexa (TLS green)

  • Scheduled childrens vaccinations have been changed. Infanrix hexa is replacing Pediacel and Infanrix IPV + Hib.

Last updated by: Emily Knight on 07-08-2017 15:19